Clinical biomarkers may guide therapy selection in RAS wildtype mCRC Presented ByDr Julian Holch, Ludwig-Maximilians-University of Munich, Germany TrialPhase 3, FIRE-3 (AIO KRK0306) ConferenceASCO GI 2024 13 February, 2024 12:31